Everolimus Plus Letrozole for Treatment of Patients With HR + , HER2 – Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial
Everolimus Plus Letrozole for Treatment of Patients With HR + , HER2 – Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial
Authors
Keywords
Advanced breast cancer, Endocrine therapy, Everolimus, Hormone receptor-positive, Letrozole
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now